$NERX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PONIARD PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PONIARD PHARMACEUTICALS, INC.. Get notifications about new insider transactions in PONIARD PHARMACEUTICALS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 5.90 | 5,215 | 30,769 | 395,748 | 390.5 K to 395.7 K (+1.34 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Buy | P | 5.74 | 1 | 6 | 4,735 | 4.7 K to 4.7 K (+0.02 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Buy | P | 5.74 | 5 | 29 | 274,749 | 274.7 K to 274.7 K (0.00 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Buy | P | 5.75 | 24 | 138 | 274,744 | 274.7 K to 274.7 K (+0.01 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Buy | P | 5.90 | 62 | 366 | 4,734 | 4.7 K to 4.7 K (+1.33 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Buy | P | 5.90 | 3,620 | 21,358 | 274,720 | 271.1 K to 274.7 K (+1.34 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.74 | 3 | 17 | 178,339 | 178.3 K to 178.3 K (0.00 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.74 | 1 | 6 | 16,161 | 16.2 K to 16.2 K (+0.01 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.74 | 20 | 115 | 891,697 | 891.7 K to 891.7 K (0.00 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.74 | 3 | 17 | 96,102 | 96.1 K to 96.1 K (0.00 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.74 | 97 | 557 | 4,458,481 | 4.5 M to 4.5 M (0.00 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.75 | 15 | 86 | 178,334 | 178.3 K to 178.3 K (+0.01 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.75 | 1 | 6 | 16,160 | 16.2 K to 16.2 K (+0.01 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.75 | 78 | 449 | 891,677 | 891.6 K to 891.7 K (+0.01 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.75 | 8 | 46 | 96,099 | 96.1 K to 96.1 K (+0.01 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.75 | 392 | 2,254 | 4,458,384 | 4.5 M to 4.5 M (+0.01 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.90 | 43 | 254 | 3,232 | 3.2 K to 3.2 K (+1.35 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.90 | 2,348 | 13,853 | 178,319 | 176 K to 178.3 K (+1.33 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.90 | 213 | 1,257 | 16,159 | 15.9 K to 16.2 K (+1.34 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.90 | 11,747 | 69,307 | 891,599 | 879.9 K to 891.6 K (+1.34 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.90 | 1,266 | 7,469 | 96,091 | 94.8 K to 96.1 K (+1.34 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.90 | 58,734 | 346,531 | 4,457,992 | 4.4 M to 4.5 M (+1.34 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 5.75 | 6 | 34 | 6,435 | 6.4 K to 6.4 K (+0.09 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 5.75 | 346 | 1,989 | 390,532 | 390.2 K to 390.5 K (+0.09 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.75 | 3 | 17 | 3,189 | 3.2 K to 3.2 K (+0.09 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.75 | 155 | 891 | 175,971 | 175.8 K to 176 K (+0.09 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.75 | 14 | 80 | 15,946 | 15.9 K to 15.9 K (+0.09 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.75 | 780 | 4,483 | 879,852 | 879.1 K to 879.9 K (+0.09 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.75 | 84 | 483 | 94,825 | 94.7 K to 94.8 K (+0.09 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.75 | 3,902 | 22,427 | 4,399,258 | 4.4 M to 4.4 M (+0.09 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Buy | P | 5.75 | 4 | 23 | 4,672 | 4.7 K to 4.7 K (+0.09 %) |
Aug 31 2007 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Buy | P | 5.75 | 240 | 1,379 | 271,100 | 270.9 K to 271.1 K (+0.09 %) |
Aug 16 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.48 | 3 | 16 | 3,187 | 3.2 K to 3.2 K (+0.09 %) |
Aug 16 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.48 | 145 | 795 | 175,815 | 175.7 K to 175.8 K (+0.08 %) |
Aug 16 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.48 | 13 | 71 | 15,932 | 15.9 K to 15.9 K (+0.08 %) |
Aug 16 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.48 | 724 | 3,970 | 879,072 | 878.3 K to 879.1 K (+0.08 %) |
Aug 16 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.48 | 78 | 428 | 94,741 | 94.7 K to 94.7 K (+0.08 %) |
Aug 16 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.48 | 3,622 | 19,862 | 4,395,356 | 4.4 M to 4.4 M (+0.08 %) |
Aug 16 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.50 | 19 | 105 | 175,670 | 175.7 K to 175.7 K (+0.01 %) |
Aug 16 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.50 | 2 | 11 | 15,919 | 15.9 K to 15.9 K (+0.01 %) |
Aug 16 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.50 | 92 | 506 | 878,348 | 878.3 K to 878.3 K (+0.01 %) |
Aug 16 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.50 | 10 | 55 | 94,663 | 94.7 K to 94.7 K (+0.01 %) |
Aug 16 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.50 | 458 | 2,519 | 4,391,734 | 4.4 M to 4.4 M (+0.01 %) |
Aug 16 2007 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 5.48 | 5 | 27 | 6,429 | 6.4 K to 6.4 K (+0.08 %) |
Aug 16 2007 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 5.48 | 322 | 1,766 | 390,186 | 389.9 K to 390.2 K (+0.08 %) |
Aug 16 2007 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 5.50 | 1 | 6 | 6,424 | 6.4 K to 6.4 K (+0.02 %) |
Aug 16 2007 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 5.50 | 40 | 220 | 389,864 | 389.8 K to 389.9 K (+0.01 %) |
Aug 16 2007 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Buy | P | 5.48 | 4 | 22 | 4,669 | 4.7 K to 4.7 K (+0.09 %) |
Aug 16 2007 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Buy | P | 5.48 | 223 | 1,223 | 270,859 | 270.6 K to 270.9 K (+0.08 %) |
Aug 16 2007 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Buy | P | 5.50 | 1 | 6 | 4,665 | 4.7 K to 4.7 K (+0.02 %) |
Aug 16 2007 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Buy | P | 5.50 | 28 | 154 | 270,636 | 270.6 K to 270.6 K (+0.01 %) |
Aug 14 2007 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Buy | P | 5.50 | 11 | 61 | 4,664 | 4.7 K to 4.7 K (+0.24 %) |
Aug 14 2007 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Buy | P | 5.50 | 664 | 3,652 | 270,608 | 269.9 K to 270.6 K (+0.25 %) |
Aug 14 2007 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 5.50 | 16 | 88 | 6,423 | 6.4 K to 6.4 K (+0.25 %) |
Aug 14 2007 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 5.50 | 956 | 5,258 | 389,824 | 388.9 K to 389.8 K (+0.25 %) |
Aug 14 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.50 | 8 | 44 | 3,184 | 3.2 K to 3.2 K (+0.25 %) |
Aug 14 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.50 | 431 | 2,371 | 175,651 | 175.2 K to 175.7 K (+0.25 %) |
Aug 14 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.50 | 39 | 215 | 15,917 | 15.9 K to 15.9 K (+0.25 %) |
Aug 14 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.50 | 2,154 | 11,847 | 878,256 | 876.1 K to 878.3 K (+0.25 %) |
Aug 14 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.50 | 232 | 1,276 | 94,653 | 94.4 K to 94.7 K (+0.25 %) |
Aug 14 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 5.50 | 10,768 | 59,224 | 4,391,276 | 4.4 M to 4.4 M (+0.25 %) |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | President & COO | Option Exercise | A | 6.87 | 800,000 | 5,496,000 | 800,000 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | SIMON NICHOLAS J III | Director | Option Exercise | A | 7.17 | 15,000 | 107,550 | 15,000 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | WIGHT ANNA L | VP Legal | Option Exercise | A | 8.14 | 60,000 | 488,400 | 60,000 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | WIGHT ANNA L | VP Legal | Option Exercise | A | 5.98 | 20,000 | 119,600 | 20,000 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | WIGHT ANNA L | VP Legal | Option Exercise | A | 3.66 | 93,108 | 340,775 | 93,108 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | KARLIN DAVID A | Sr. VP, Clinical D ... | Option Exercise | A | 8.14 | 65,000 | 529,100 | 65,000 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | KARLIN DAVID A | Sr. VP, Clinical D ... | Option Exercise | A | 5.98 | 30,000 | 179,400 | 30,000 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | KARLIN DAVID A | Sr. VP, Clinical D ... | Option Exercise | A | 3.66 | 145,200 | 531,432 | 145,200 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | Kwok Cheni | VP, Bus. Devlpt. | Option Exercise | A | 8.14 | 21,500 | 175,010 | 21,500 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | Kwok Cheni | VP, Bus. Devlpt. | Option Exercise | A | 5.98 | 20,000 | 119,600 | 20,000 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | Kwok Cheni | VP, Bus. Devlpt. | Option Exercise | A | 3.66 | 62,500 | 228,750 | 62,500 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Option Exercise | A | 8.14 | 300,000 | 2,442,000 | 300,000 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Option Exercise | A | 5.98 | 157,500 | 941,850 | 157,500 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Option Exercise | A | 3.66 | 284,400 | 1,040,904 | 284,400 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | CFO | Option Exercise | A | 8.14 | 60,000 | 488,400 | 60,000 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | CFO | Option Exercise | A | 5.98 | 35,000 | 209,300 | 35,000 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | CFO | Option Exercise | A | 3.66 | 128,533 | 470,431 | 128,533 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | BASSO ROBERT S | Director | Option Exercise | A | 7.17 | 10,000 | 71,700 | 10,000 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Option Exercise | A | 7.17 | 15,000 | 107,550 | 15,000 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | DICKSON E ROLLAND | Director | Option Exercise | A | 7.17 | 7,500 | 53,775 | 22,500 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | DICKSON E ROLLAND | Director | Option Exercise | A | 7.17 | 15,000 | 107,550 | 15,000 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Option Exercise | A | 7.17 | 15,000 | 107,550 | 15,000 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Option Exercise | A | 7.17 | 15,000 | 107,550 | 15,000 | |
Jun 18 2007 | NERX | PONIARD PHARMACEUT ... | Littauer Robert K | Director | Option Exercise | A | 7.17 | 15,000 | 107,550 | 15,000 | |
May 01 2007 | NERX | PONIARD PHARMACEUT ... | MPM BIOVENTURES III LLC | 10% Owner | Buy | P | 6.33 | 900,000 | 5,697,000 | 6,858,211 | 6 M to 6.9 M (+15.11 %) |
May 01 2007 | NERX | PONIARD PHARMACEUT ... | EVNIN LUKE | 10% Owner | Buy | P | 6.33 | 900,000 | 5,697,000 | 6,858,211 | 6 M to 6.9 M (+15.11 %) |
May 23 2007 | NERX | PONIARD PHARMACEUT ... | BASSO ROBERT S | Director | Option Exercise | A | 6.81 | 8,333 | 56,748 | 8,333 | |
May 01 2007 | NERX | PONIARD PHARMACEUT ... | SIMON NICHOLAS J III | Director | Buy | P | 6.33 | 900,000 | 5,697,000 | 6,858,211 | 6 M to 6.9 M (+15.11 %) |
Apr 30 2007 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Buy | P | 6.33 | 936 | 5,925 | 4,653 | 3.7 K to 4.7 K (+25.18 %) |
Apr 30 2007 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Buy | P | 6.33 | 54,291 | 343,662 | 269,944 | 215.7 K to 269.9 K (+25.18 %) |
Apr 30 2007 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 6.33 | 1,289 | 8,159 | 6,407 | 5.1 K to 6.4 K (+25.19 %) |
Apr 30 2007 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 6.33 | 78,209 | 495,063 | 388,868 | 310.7 K to 388.9 K (+25.18 %) |
Apr 30 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | P | 6.33 | 639 | 4,045 | 3,176 | 3.8 K to 3.2 K (-16.75 %) |
Apr 30 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Sell | P | 6.33 | 35,240 | 223,069 | 175,220 | 210.5 K to 175.2 K (-16.74 %) |
Apr 30 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 6.33 | 3,193 | 20,212 | 15,878 | 12.7 K to 15.9 K (+25.17 %) |
Apr 30 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 6.33 | 176,202 | 1,115,359 | 876,102 | 699.9 K to 876.1 K (+25.18 %) |
Apr 30 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 6.33 | 18,990 | 120,207 | 94,421 | 75.4 K to 94.4 K (+25.18 %) |
Apr 30 2007 | NERX | PONIARD PHARMACEUT ... | BAY CITY CAPITAL LLC | 10% Owner | Buy | P | 6.33 | 881,010 | 5,576,793 | 4,380,508 | 3.5 M to 4.4 M (+25.18 %) |
Jul 25 2006 | NERX | PONIARD PHARMACEUT ... | Glassberg Alan B M.D. | Chief Medical Offic ... | Option Exercise | A | 0.77 | 600,000 | 462,000 | 600,000 | |
Jul 12 2006 | NERX | PONIARD PHARMACEUT ... | Kwok Cheni | VP, Bus. Devlpt. | Option Exercise | A | 0.84 | 225,000 | 189,000 | 225,000 | |
Jun 26 2006 | NERX | PONIARD PHARMACEUT ... | Loewy Caroline M | EVP, Planning & IR | Option Exercise | A | 1.00 | 600,000 | 600,000 | 600,000 | |
Jun 27 2006 | NERX | PONIARD PHARMACEUT ... | MARTELL RON | Director | Option Exercise | A | 1.00 | 50,000 | 50,000 | 50,000 | |
Jun 20 2006 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Option Exercise | A | 1.08 | 1,000,000 | 1,080,000 | 1,000,000 | |
Jun 20 2006 | NERX | PONIARD PHARMACEUT ... | STEIGROD ALAN A | Director | Option Exercise | A | 1.08 | 45,000 | 48,600 | 45,000 | |
Jun 20 2006 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Option Exercise | A | 1.08 | 45,000 | 48,600 | 45,000 | |
Jun 20 2006 | NERX | PONIARD PHARMACEUT ... | Littauer Robert K | Director | Option Exercise | A | 1.08 | 45,000 | 48,600 | 45,000 | |
Jun 20 2006 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Option Exercise | A | 1.08 | 45,000 | 48,600 | 45,000 | |
Jun 20 2006 | NERX | PONIARD PHARMACEUT ... | DICKSON E ROLLAND | Director | Option Exercise | A | 1.08 | 45,000 | 48,600 | 45,000 | |
Jun 20 2006 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Option Exercise | A | 1.08 | 500,000 | 540,000 | 500,000 | |
Jun 20 2006 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Option Exercise | A | 1.08 | 45,000 | 48,600 | 45,000 | |
May 02 2006 | NERX | PONIARD PHARMACEUT ... | KARLIN DAVID A | Sr. VP, Clinical D ... | Option Exercise | A | 1.25 | 250,000 | 312,500 | 250,000 | |
May 02 2006 | NERX | PONIARD PHARMACEUT ... | WIGHT ANNA L | VP Legal | Option Exercise | A | 1.25 | 250,000 | 312,500 | 250,000 | |
May 02 2006 | NERX | PONIARD PHARMACEUT ... | Berland Susan D | CFO | Option Exercise | A | 1.25 | 250,000 | 312,500 | 250,000 | |
May 02 2006 | NERX | PONIARD PHARMACEUT ... | DICKSON E ROLLAND | Director | Option Exercise | A | 1.25 | 125,000 | 156,250 | 125,000 | |
May 02 2006 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Option Exercise | A | 1.25 | 250,000 | 312,500 | 250,000 | |
May 02 2006 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Option Exercise | A | 1.25 | 125,000 | 156,250 | 125,000 | |
May 02 2006 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Option Exercise | A | 1.25 | 125,000 | 156,250 | 125,000 | |
May 02 2006 | NERX | PONIARD PHARMACEUT ... | Littauer Robert K | Director | Option Exercise | A | 1.25 | 125,000 | 156,250 | 125,000 | |
May 02 2006 | NERX | PONIARD PHARMACEUT ... | STEIGROD ALAN A | Director | Option Exercise | A | 1.25 | 125,000 | 156,250 | 125,000 | |
May 02 2006 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Option Exercise | A | 1.25 | 125,000 | 156,250 | 125,000 | |
Apr 28 2006 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Option Exercise | P | 0.77 | 517,465 | 398,448 | 517,465 | |
Apr 28 2006 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | P | 0.70 | 1,792,054 | 1,254,438 | 1,894,664 | 102.6 K to 1.9 M (+1,746.47 %) |
Apr 28 2006 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Buy | C | 0.70 | 102,610 | 71,827 | 102,610 | 0 to 102.6 K |
Apr 28 2006 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Option Exercise | P | 0.77 | 359,481 | 276,800 | 359,481 | |
Apr 28 2006 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Buy | P | 0.70 | 1,244,935 | 871,455 | 1,316,218 | 71.3 K to 1.3 M (+1,746.47 %) |
Apr 28 2006 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Buy | C | 0.70 | 71,283 | 49,898 | 71,283 | 0 to 71.3 K |
Apr 27 2006 | NERX | PONIARD PHARMACEUT ... | SIMON NICHOLAS J III | Director | Option Exercise | A | 1.28 | 50,000 | 64,000 | 50,000 | |
Feb 16 2006 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Option Exercise | J | 0.77 | 50,377 | 38,790 | 50,377 | |
Feb 16 2006 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Option Exercise | J | 0.77 | 34,997 | 26,948 | 34,997 | |
Jul 05 2005 | NERX | PONIARD PHARMACEUT ... | KARLIN DAVID A | Sr. VP, Clinical D ... | Option Exercise | A | 0.62 | 250,000 | 155,000 | 250,000 | |
Jun 17 2005 | NERX | PONIARD PHARMACEUT ... | STEIGROD ALAN A | Director | Option Exercise | A | 0.67 | 20,000 | 13,400 | 95,000 | |
Jun 17 2005 | NERX | PONIARD PHARMACEUT ... | STEIGROD ALAN A | Director | Option Exercise | A | 0.67 | 75,000 | 50,250 | 75,000 | |
Jun 16 2005 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Option Exercise | A | 0.67 | 20,000 | 13,400 | 95,000 | |
Jun 16 2005 | NERX | PONIARD PHARMACEUT ... | Littauer Robert K | Director | Option Exercise | A | 0.67 | 20,000 | 13,400 | 95,000 | |
Jun 16 2005 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Option Exercise | A | 0.67 | 20,000 | 13,400 | 95,000 | |
Jun 16 2005 | NERX | PONIARD PHARMACEUT ... | Glassberg Alan B M.D. | Director | Option Exercise | A | 0.67 | 20,000 | 13,400 | 95,000 | |
Jun 16 2005 | NERX | PONIARD PHARMACEUT ... | DICKSON E ROLLAND | Director | Option Exercise | A | 0.67 | 20,000 | 13,400 | 100,000 | |
Jun 16 2005 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Option Exercise | A | 0.67 | 20,000 | 13,400 | 95,000 | |
Jun 16 2005 | NERX | PONIARD PHARMACEUT ... | CRAVES FRED B | Director | Option Exercise | A | 0.67 | 75,000 | 50,250 | 75,000 | |
Jun 16 2005 | NERX | PONIARD PHARMACEUT ... | DICKSON E ROLLAND | Director | Option Exercise | A | 0.67 | 80,000 | 53,600 | 80,000 | |
Jun 16 2005 | NERX | PONIARD PHARMACEUT ... | Glassberg Alan B M.D. | Director | Option Exercise | A | 0.67 | 75,000 | 50,250 | 75,000 | |
Jun 16 2005 | NERX | PONIARD PHARMACEUT ... | GOLDFISCHER CARL | Director | Option Exercise | A | 0.67 | 75,000 | 50,250 | 75,000 | |
Jun 16 2005 | NERX | PONIARD PHARMACEUT ... | Littauer Robert K | Director | Option Exercise | A | 0.67 | 75,000 | 50,250 | 75,000 | |
Jun 16 2005 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Option Exercise | A | 0.67 | 75,000 | 50,250 | 75,000 | |
May 23 2005 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Buy | P | 0.55 | 7,155 | 3,935 | 34,500 | 27.3 K to 34.5 K (+26.17 %) |
May 23 2005 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Buy | P | 0.53 | 500 | 265 | 27,345 | 26.8 K to 27.3 K (+1.86 %) |
May 23 2005 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Buy | P | 0.52 | 4,395 | 2,285 | 26,845 | 22.5 K to 26.8 K (+19.58 %) |
May 23 2005 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Buy | P | 0.50 | 15,403 | 7,702 | 22,450 | 7 K to 22.5 K (+218.58 %) |
May 23 2005 | NERX | PONIARD PHARMACEUT ... | Stevens David R | Director | Buy | P | 0.49 | 6,047 | 2,963 | 7,047 | 1,000 to 7 K (+604.70 %) |